Skip to main content

Advertisement

Log in

Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Summary

We comprehensively described elderly Medicare women with an outpatient visit in 2011 and fracture within 2 years before. These women were at very high risk for subsequent fracture and high healthcare utilization and cost, especially those with vertebral or multiple fractures. However, rates of fracture prevention treatments were low.

Introduction

Postmenopausal women with osteoporosis are stratified to high and very-high fracture risk categories, and this categorization drives algorithms for osteoporosis management in osteoporosis treatment guidelines. This study comprehensively describes a very-high-risk cohort.

Methods

This retrospective cohort study used the Medicare 20% database; elderly women with an outpatient visit in 2011 and fracture within 2 years before the visit were included. Outcomes included fracture risk, all-cause and fracture-related healthcare resource utilization and cost, and osteoporosis medication use in the 5 years after the visit.

Results

Overall, 43,193 patients were included. The 5-year probability was 0.36 for major fracture and 0.11 and 0.17 for hip fracture and vertebral fracture, respectively, much higher than the guidelines’ 10-year probability thresholds for very-high-risk (0.3 for major fracture, 0.045 for hip fracture). Rates of hospitalizations, emergency department visits or observation stays, and skilled nursing facility stays in year 1 were 53.7, 57.0, and 18.8 per 100 patient-years, respectively, decreasing slightly in subsequent years. Mean healthcare cost was $23,700 in year 1, decreasing to $18,500 in year 5. About 29.1% of patients received osteoporosis medications in year 1, decreasing to 16.9% by year 5. Rates for all outcomes, especially fractures, were much higher among vertebral and multiple fracture cohorts.

Conclusion

Elderly women with a fracture within last 2 years were at very-high-risk for subsequent fracture and high healthcare utilization and cost, especially those with vertebral or multiple fractures. However, rates of fracture prevention treatments were low. More effort is needed to identify and treat patients at very-high-risk for fracture.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Wade SW, Strader C, Fitzpatrick LA, Anthony MS (2012) Sex- and age-specific incidence of non-traumatic fractures in selected industrialized countries. Arch Osteoporos 7:219–227

    Article  CAS  Google Scholar 

  2. Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17(12):1726–1733

    Article  CAS  Google Scholar 

  3. Gullberg B, Johnell O, Kanis JA (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407–413

    Article  CAS  Google Scholar 

  4. United Nations. Department of Economic and Social Affairs, Population Division (2013) World population ageing 2013. ST/ESA/SER.A/348. 2013; Available at: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf. Accessed June 23, 2020

  5. Peeters CM, Visser E, Van de Ree CL, Gosens T, Den Oudsten BL, De Vries J (2016) Quality of life after hip fracture in the elderly: a systematic literature review. Injury. 47(7):1369–1382

    Article  Google Scholar 

  6. Burge R, Dawson-Hughes B, Solomon DH et al (2007) Incidence and economic burden of osteoporosis-related fractures in the United States 2005-2025. J Bone Miner Res 22:465–475

    Article  Google Scholar 

  7. Weycker D, Li X, Barron R, Bornheimer R, Chandler D (2016) Hospitalizations for osteoporosis-related fractures: economic costs and clinical outcomes. Bone Rep 5:186–191

    Article  Google Scholar 

  8. Singer A, Exuzides A, Spangler L et al (2015) Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc 90(1):53–62

    Article  Google Scholar 

  9. Dyer SM, Crotty M, Fairhall N, for the Fragility Fracture Network (FFN) et al (2016) Rehabilitation Research Special Interest Group. A critical review of the long-term disability outcomes following hip fracture. BMC Geriatr 16(1):158

    Article  Google Scholar 

  10. Xiao P, Zhou Y (2020) Factors associated with the burden of family caregivers of elderly patients with femoral neck fracture: a cross-sectional study. J Orthop Surg Res 15:234. Published online 2020 Jun 23. doi: https://doi.org/10.1186/s13018-020-01749-9

  11. Johansson H, Siggeirsdóttir K, Harver NC et al (2017) Imminent risk of fracture after fracture. Osteoporos Int. 28(3):775–780

    Article  CAS  Google Scholar 

  12. Banefelt J, Åkesson KE, Spångéus A et al (2019) Risk of imminent fracture following a previous fracture in a Swedish database study. Osteoporos Int 30(3):601–609

    Article  CAS  Google Scholar 

  13. Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297(4):387–394

    Article  CAS  Google Scholar 

  14. Camacho PM, Petak SM, Binkley N et al (2020) American Association of Clinical Endocrinologists Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis - 2020 update. Endocr Pract 26(5):564–570. https://doi.org/10.4158/GL-2020-0524

    Article  PubMed  Google Scholar 

  15. Curtis JR, Mudano AS, Solomon DH, Xi J, Melton ME, Saag KG (2009) Identification and validation of vertebral compression fractures using administrative claims data. Med Care 47(1):69–72

    Article  Google Scholar 

  16. Liu J, Guo H, Rai P, Pinto L, Barron R (2018) Medication persistence and risk of fracture among female Medicare beneficiaries diagnosed with osteoporosis. Osteoporos Int 29(11):2409–2417

    Article  CAS  Google Scholar 

  17. Johnell O, Kanis JA, Oden A et al (2004) Fracture risk following an osteoporotic fracture. Osteoporos Int. 15:175–179

    Article  CAS  Google Scholar 

  18. Johnell O, Oden A, Caulin F, Kanis JA (2001) Acute and long term increase in fracture risk after hospitalization for vertebral fracture. Osteoporos Int. 12:207–214

    Article  CAS  Google Scholar 

  19. Giangregorio LM, Leslie WD (2010) Manitoba Bone Density Program. Time since prior fracture is a risk modifier for 10-year osteoporotic fractures. J Bone Miner Res. 25:1400–1405

    Article  Google Scholar 

  20. Hansen D, Bazell C, Pelizzari P, Pyenson B. Medicare cost of osteoporotic fractures, the clinical and cost burden of an important consequence of osteoporosis. Milliman Research Report, August 2019. http://assets.milliman.com/ektron/Medicare_cost_of_osteoporotic_fractures.pdf. Accessed October 19, 2020.

  21. Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, Trial HRF (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 357:1799–1809

    Article  CAS  Google Scholar 

  22. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 344:1434–1441

    Article  CAS  Google Scholar 

  23. Wang C-Y, Shau-Huai F, Yang R-S, Chen L-K, Shen L-J, Hsiao F-Y (2020) Timing of anti-osteoporosis medications initiation after a hip fracture affects the risk of subsequent fracture: a nationwide cohort study. Bone 138:115452

    Article  Google Scholar 

  24. Kim S-M, Kang K-C, Kim JW, Lim S-J, Hahn MH (2017) Current role and application of teriparatide in fracture healing of osteoporotic patients: a systematic review. J Bone Metab 24(1):65–73

    Article  Google Scholar 

  25. Centers for Medicare & Medicaid Services. Medicare utilization and payment section. Hospitalization. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMSProgramStatistics/2015/2015_Utilization#Medicare_Inpatient_Hospital. Accessed June 23, 2020.

  26. Shane E, Burr D (2010) Peter R Ebeling, et al. (2010). Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 25(11):2267–2294

    Article  Google Scholar 

  27. Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG, Shane E (2017) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res. 32(3):424–430

    Article  Google Scholar 

  28. Kaiser Family Foundation. Medicare spending per enrollee by state. 2014. https://www.kff.org/medicare/state-indicator/per-enrollee-spending-by-residence/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D. Accessed June 23, 2020.

  29. Centers for Medicare & Medicaid Services. Medicare utilization and payment section. Utilization. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/CMSProgramStatistics/2015/2015_Utilization. Accessed June 23, 2020.

Download references

Acknowledgements

The authors thank Chronic Disease Research Group colleague Mary Van Beusekom, MS, ELS, for manuscript editing.

Availability of data and material

The Medicare data used for this study was licensed through the Centers for Medicare & Medicaid Services and cannot be shared outside of that agreement.

Code availability

Proprietary programming code was developed to analyze the Medicare data and not available outside of the study team.

Funding

This study was supported by Amgen Inc., Thousand Oaks, CA.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. Liu.

Ethics declarations

Ethics approval

Institutional review board approval was obtained through the Hennepin Healthcare Research Institute, Office for Human Subjects Research.

Conflicts of interest

MO, SRG, and XX are employees of Amgen and stockholders; JL and TG are employees of CDRG and CDRG received research support from Amgen; and KNF is employee of Strategic Healthcare Solutions and contracted with Amgen.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, J., Gong, T., Xu, X. et al. Heavy clinical and economic burden of osteoporotic fracture among elderly female Medicare beneficiaries. Osteoporos Int 33, 413–423 (2022). https://doi.org/10.1007/s00198-021-06084-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-021-06084-1

Keywords

Navigation